Machine learning enhances proteomics by optimizing peptide identification, structure prediction, and biomarker discovery.
Machine learning predicts who will decline faster in Alzheimer’s disease using routine clinic data
Researchers developed and validated ElasticNet machine learning models that predict 12-month MMSE and BADL outcomes in ...
Read more about AI-driven air quality system promises faster, more reliable urban health warnings on Devdiscourse ...
Machine learning for health data science, fuelled by proliferation of data and reduced computational costs, has garnered considerable interest among researchers. The debate around the use of machine ...
Support vector machines improve classification by mapping inseparable signals into higher-dimensional spaces. Random forest models, through ensemble decision trees, increase robustness against ...
Physical artificial intelligence (PAI) is the application of AI and machine learning (ML) algorithms to enable autonomous ...
The Computer Vision Image Software Market size was valued at USD 14.72 billion in 2025 and is expected to reach USD 52.49 billion by 2035, expanding at a CAGR of 13.56% over the forecast period of ...
A blood sample does not have an obvious odor to a person in a lab coat. But to an electronic nose, it can carry a chemical signature that points toward disease.
Companies like Apple and Qualcomm are in the early stages of making on-device AI more useful. Amid all that, the 14-person ...
Objective Cardiovascular diseases (CVD) remain the leading cause of mortality globally, necessitating early risk identification to improve prevention and management strategies. Traditional risk ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results